These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Cedarbaum J; Green RC; Harvey D; Jack CR; Jagust W; Luthman J; Morris JC; Petersen RC; Saykin AJ; Shaw L; Shen L; Schwarz A; Toga AW; Trojanowski JQ; Alzheimers Dement; 2015 Jun; 11(6):e1-120. PubMed ID: 26073027 [TBL] [Abstract][Full Text] [Related]
4. Association of Plasma Transferrin With Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer's Disease. Guan J; Wang P; Lu L; Zhao G Front Aging Neurosci; 2020; 12():38. PubMed ID: 32226377 [No Abstract] [Full Text] [Related]
6. Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition. Tan YJ; Siow I; Saffari SE; Ting SKS; Li Z; Kandiah N; Tan LCS; Tan EK; Ng ASL J Alzheimers Dis; 2023; 92(2):573-580. PubMed ID: 36776067 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic Efficacy of Plasmalogens for Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease in Conjunction with a New Hypothesis for the Etiology of Alzheimer's Disease. Fujino T; Hossain MS; Mawatari S Adv Exp Med Biol; 2020; 1299():195-212. PubMed ID: 33417216 [TBL] [Abstract][Full Text] [Related]
8. Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease. Jongbloed W; van Dijk KD; Mulder SD; van de Berg WD; Blankenstein MA; van der Flier W; Veerhuis R J Alzheimers Dis; 2015; 46(4):1103-10. PubMed ID: 26402636 [TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's Disease. Johar I; Mollenhauer B; Aarsland D Int Rev Neurobiol; 2017; 132():275-294. PubMed ID: 28554411 [TBL] [Abstract][Full Text] [Related]
11. Neural evidence for defective top-down control of visual processing in Parkinson's and Alzheimer's disease. Nemcova Elfmarkova N; Gajdos M; Rektorova I; Marecek R; Rapcsak SZ Neuropsychologia; 2017 Nov; 106():236-244. PubMed ID: 28974380 [TBL] [Abstract][Full Text] [Related]
12. Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction. Saka E; Elibol B Parkinsonism Relat Disord; 2009 Nov; 15(9):688-91. PubMed ID: 19446489 [TBL] [Abstract][Full Text] [Related]
13. Is Mild Cognitive Impairment a Precursor of Alzheimer's Disease? Short Review. Janoutová J; Šerý O; Hosák L; Janout V Cent Eur J Public Health; 2015 Dec; 23(4):365-7. PubMed ID: 26841152 [TBL] [Abstract][Full Text] [Related]
14. Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease. Chen-Plotkin AS; Hu WT; Siderowf A; Weintraub D; Goldmann Gross R; Hurtig HI; Xie SX; Arnold SE; Grossman M; Clark CM; Shaw LM; McCluskey L; Elman L; Van Deerlin VM; Lee VM; Soares H; Trojanowski JQ Ann Neurol; 2011 Apr; 69(4):655-63. PubMed ID: 21520231 [TBL] [Abstract][Full Text] [Related]
15. Parkinson's and Alzheimer's diseases: Focus on mild cognitive impairment. Korczyn AD Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S159-61. PubMed ID: 26516060 [TBL] [Abstract][Full Text] [Related]
16. Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study. Kalbe E; Rehberg SP; Heber I; Kronenbuerger M; Schulz JB; Storch A; Linse K; Schneider C; Gräber S; Liepelt-Scarfone I; Berg D; Dams J; Balzer-Geldsetzer M; Hilker R; Oberschmidt C; Witt K; Schmidt N; Mollenhauer B; Trenkwalder C; Spottke A; Roeske S; Wittchen HU; Riedel O; Dodel R J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1099-105. PubMed ID: 27401782 [TBL] [Abstract][Full Text] [Related]
17. Association of arterial stiffness with cognition in patients with Lewy body disorder. Ryu DW; Kim JS; Lee JE; Park JW; Oh YS; An JY; Lee KS Neurol Sci; 2017 Jul; 38(7):1307-1313. PubMed ID: 28474150 [TBL] [Abstract][Full Text] [Related]
18. Retinal Nerve Fiber Layer Thinning in Alzheimer's Disease: A Case-Control Study in Comparison to Normal Aging, Parkinson's Disease, and Non-Alzheimer's Dementia. Pillai JA; Bermel R; Bonner-Jackson A; Rae-Grant A; Fernandez H; Bena J; Jones SE; Ehlers JP; Leverenz JB Am J Alzheimers Dis Other Demen; 2016 Aug; 31(5):430-6. PubMed ID: 26888864 [TBL] [Abstract][Full Text] [Related]